Nav: Home

In the fight to control glucose levels, this control algorithm comes out on top

June 13, 2016

The so-called artificial pancreas -- an automated insulin delivery system for people type 1 diabetes mellitus -- uses an advanced control algorithm to regulate how much insulin a pump should deliver and when. Regulating glucose is challenging because levels respond to a wide-array of variables, including food, physical activity, sleep, stress, hormones, metabolism and more.

For years, researchers have been trying to find the best control algorithm to account for and control for all these variables. Over the years, two primary control strategies emerged as the front-runners -- model predictive control (MPC) and proportional integral derivative (PID). There has been a long-running debate in the field over which of these controls works better.

Now, researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences and the William Sansum Diabetes Center have conducted the first head-to-head randomized crossover evaluation of the two controls under comparable clinical conditions. The team found that MPC outperformed PID on the primary outcome of the study, as well as on several secondary outcomes.

The research was presented by Frank Doyle, Dean of the Harvard Paulson School of Engineering and Applied Sciences and senior author of the study at the American Diabetes Association 2016 meeting in New Orleans and published in the journal Diabetes Care.

"This research won't put an end to the debate because both controls worked well," said Eyal Dassau, Senior Research Fellow in Biomedical Engineering at SEAS, and co-author of the paper. "But we showed that there are scenarios in which MPC is superior, due to the flexibility of that design. This is the first real head-to-head clinical study that compares the two lead controllers in identical conditions with the same population in a randomized crossover study."

"What is remarkable here is that we used a very basic formulation of MPC, and it still outperformed PID," said Doyle, who is also the John A. & Elizabeth S. Armstrong Professor of Engineering & Applied Sciences. "We have much more sophisticated versions of the algorithm that have been tested on hundreds of subjects and are in the early stages of commercial development. It is a remarkable flexible and powerful algorithm."

Doyle and Dassau were collaborators at the University of California, Santa Barbara before joining Harvard in the fall of 2015.

An artificial pancreas system controlled with a PID system is reactive, like a home thermostat adjusting temperature. But MPC is proactive, allowing the system to think multiple steps ahead, predicting when the body may need more or less insulin and planning in advance.

The clinical study consisted of 30 adults with type 1 diabetes. They were randomly assigned either a PID or MPC control for the first round of the study and then switched for the second.

Every participant had the same food to eat and the same schedule for eating. The researchers observed how the system responded to announced meals, when insulin is manually administered before a meal; unannounced meals, to simulate when people forget to increase insulin before eating; how the system controlled insulin during before and after breakfast, when insulin resistance increases due to hormones; and overnight control.

The researchers monitored the glucose levels of the participants in real time, at five minute intervals.

The team found that while both controls worked, MPC kept participants within the safe glucose range 74 percent of the time, while PID kept them in range 64 percent of the time including an unannounced meal. The mean glucose values for each subject were also statistically lower for MPC compared to PID.

Being able to predict those highs and lows and provide optimal insulin delivery is a big part of MPC's success, said Dassau.

"With MPC, we have a vision into the future and can make course corrections before something bad happens like hypoglycemia," he said. "The model can identify a drift and course correct gradually without causing a crash landing. PID on its own does not have that prediction capability."

The next steps are to conduct longer, outpatient studies to learn how to adapt the system to long-term changes in stress, activity level, weight gain or loss, etc. The ultimate goal is to create a system that can adapt to all of these changes with minimal patient involvement.

"Diabetes is a unique disease in that patients are very involved in their own therapy and are required to put a lot of trust in an automated system," Dassau said. "Our goal is to improve that trust and make it so that users can spend less time on diabetes."
-end-


Harvard John A. Paulson School of Engineering and Applied Sciences

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
New cause of diabetes
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.

Related Diabetes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#520 A Closer Look at Objectivism
This week we broach the topic of Objectivism. We'll be speaking with Keith Lockitch, senior fellow at the Ayn Rand Institute, about the philosophy of Objectivism as it's taught through Ayn Rand's writings. Then we'll speak with Denise Cummins, cognitive scientist, author and fellow at the Association for Psychological Science, about the impact of Objectivist ideology on society. Related links: This is what happens when you take Ayn Rand seriously Another Critic Who Doesn’t Care What Rand Thought or Why She Thought It, Only That She’s Wrong Quote is from "A Companion to Ayn Rand"